| Recent advances in understanding enteric pathogenic Escherichia coli MA Croxen, RJ Law, R Scholz, KM Keeney, M Wlodarska, BB Finlay Clinical microbiology reviews 26 (4), 822-880, 2013 | 1969 | 2013 |
| Molecular mechanisms of Escherichia coli pathogenicity MA Croxen, BB Finlay Nature Reviews Microbiology 8 (1), 26-38, 2010 | 1631 | 2010 |
| Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori, Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuni PS Hoffman, G Sisson, MA Croxen, K Welch, WD Harman, N Cremades, ... Antimicrobial agents and chemotherapy 51 (3), 868-876, 2007 | 309 | 2007 |
| The Helicobacter pylori Chemotaxis Receptor TlpB (HP0103) Is Required for pH Taxis and for Colonization of the Gastric Mucosa MA Croxen, G Sisson, R Melano, PS Hoffman Journal of bacteriology 188 (7), 2656-2665, 2006 | 236 | 2006 |
| The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization RBR Ferreira, N Gill, BP Willing, LCM Antunes, SL Russell, MA Croxen, ... PloS one 6 (5), e20338, 2011 | 220 | 2011 |
| Altering host resistance to infections through microbial transplantation BP Willing, A Vacharaksa, M Croxen, T Thanachayanont, BB Finlay PloS one 6 (10), e26988, 2011 | 219 | 2011 |
| Infection control in the new age of genomic epidemiology P Tang, MA Croxen, MR Hasan, WWL Hsiao, LM Hoang American journal of infection control 45 (2), 170-179, 2017 | 119 | 2017 |
| Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation HP Sham, SR Shames, MA Croxen, C Ma, JM Chan, MA Khan, ... Infection and immunity 79 (9), 3552-3562, 2011 | 110 | 2011 |
| A comprehensive method for amplicon-based and metagenomic characterization of viruses, bacteria, and eukaryotes in freshwater samples MI Uyaguari-Diaz, M Chan, BL Chaban, MA Croxen, JF Finke, JE Hill, ... Microbiome 4, 1-19, 2016 | 104 | 2016 |
| Autophagy Facilitates Salmonella Replication in HeLa Cells HB Yu, MA Croxen, AM Marchiando, RBR Ferreira, K Cadwell, LJ Foster, ... MBio 5 (2), 10.1128/mbio. 00865-14, 2014 | 94 | 2014 |
| A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium W Deng, CL de Hoog, BY Hong, Y Li, MA Croxen, NA Thomas, JL Puente, ... Journal of Biological Chemistry 285 (9), 6790-6800, 2010 | 88 | 2010 |
| Flavodoxin: quinone reductase (FqrB): a redox partner of pyruvate: ferredoxin oxidoreductase that reversibly couples pyruvate oxidation to NADPH production in Helicobacter … M St. Maurice, N Cremades, MA Croxen, G Sisson, J Sancho, PS Hoffman Journal of Bacteriology 189 (13), 4764-4773, 2007 | 82 | 2007 |
| The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300 SR Shames, AP Bhavsar, MA Croxen, RJ Law, SHC Mak, W Deng, Y Li, ... Cellular microbiology 13 (10), 1542-1557, 2011 | 70 | 2011 |
| A comprehensive study of the contribution of Salmonella enterica serovar Typhimurium SPI2 effectors to bacterial colonization, survival, and replication in typhoid … MMC Buckner, M Croxen, ET Arena, BB Finlay Virulence 2 (3), 208-216, 2011 | 70 | 2011 |
| Paradoxical clade-and age-specific vaccine effectiveness during the 2018/19 influenza A (H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV) DM Skowronski, S Sabaiduc, S Leir, C Rose, M Zou, M Murti, ... Eurosurveillance 24 (46), 1900585, 2019 | 68 | 2019 |
| The deubiquitinase activity of the Salmonella pathogenicity island 2 effector, SseL, prevents accumulation of cellular lipid droplets ET Arena, SD Auweter, LCM Antunes, AW Vogl, J Han, JA Guttman, ... Infection and Immunity 79 (11), 4392-4400, 2011 | 64 | 2011 |
| Human activity determines the presence of integron-associated and antibiotic resistance genes in Southwestern British Columbia MI Uyaguari-Díaz, MA Croxen, Z Luo, KI Cronin, M Chan, WN Baticados, ... Frontiers in microbiology 9, 852, 2018 | 57 | 2018 |
| Interim estimates of 2018/19 vaccine effectiveness against influenza A (H1N1) pdm09, Canada, January 2019 DM Skowronski, S Leir, S Sabaiduc, M Murti, JA Dickinson, R Olsha, ... Eurosurveillance 24 (4), 1900055, 2019 | 56 | 2019 |
| mcr-1–positive colistin-resistant Escherichia coli in traveler returning to Canada from China M Payne, MA Croxen, TD Lee, B Mayson, S Champagne, V Leung, ... Emerging infectious diseases 22 (9), 1673, 2016 | 55 | 2016 |
| Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020 DM Skowronski, M Zou, S Sabaiduc, M Murti, R Olsha, JA Dickinson, ... Eurosurveillance 25 (7), 2000103, 2020 | 47 | 2020 |
